ASCO: NADINA Supports Neoadjuvant IO For Melanoma

 
• By Mary Jo Laffler
  
Asco 2024, main hall
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from ASCO

More from Conferences